TGA approves first treatment for geographic atrophy
07 February, 2025Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.
Specially designed peptides can treat complex diseases
06 February, 2025Two separate research teams have found ways to create short chains of amino acids, termed peptides, for the purpose of treating a variety of diseases — including cancer.
New drug to prevent migraine claimed to work straight away
21 January, 2025People taking atogepant showed improvement on assessments of how much migraine impaired their activities and their overall quality of life compared to people taking a placebo.
Targeting the stress system reduces Parkinson's tremors
16 January, 2025The commonly used Parkinson's drug levodopa usually helps with tremors, but it tends to be less effective during stress, when tremors are often at their worst.
ADHD drug shows promise for treating meth addiction
13 January, 2025A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence.
Gene therapy reverses heart failure in large animal model
13 December, 2024The therapy increases the amount of blood the heart can pump and dramatically improves survival, in an apparently unprecedented recovery of cardiac function.
A new way to cross the blood–brain barrier
04 December, 2024The blood–brain barrier-crossing conjugate (BCC) system is designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system.
Oxytocin analogue treats chronic abdominal pain
29 November, 2024Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain, based on the peptide hormone known as oxytocin.
Three-in-one pill could transform hypertension treatment
28 November, 2024Australian research has produced impressive Phase III clinical trial results for an innovative combination of drugs, which could revolutionise the management of high blood pressure.
FDA approves new treatment for graft-versus-host disease
19 November, 2024Back in 2014, Dr Kelli MacDonald's lab at QIMR Berghofer identified the cellular process causing chronic GVHD as well as the antibody that could block this process.
Drug delays tumour growth in models of children's liver cancer
15 November, 2024A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma, a type of liver cancer that occurs in young children.
Cancer drug eliminates bone metastasis in lab models
08 November, 2024Researchers have developed a novel treatment that is specific to breast cancer bone metastasis and can successfully work in the bone microenvironment, which is often resistant to therapeutics.
TGA rejects Alzheimer's drug due to safety concerns
07 November, 2024The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did not outweigh the safety risks associated with its use.
Towards safer epilepsy treatment for pregnant women
29 October, 2024New research conducted in organoids is expected to provide pregnant women with epilepsy safer access to a common and highly effective anti-seizure medication.
Epilepsy drug shows promise for obstructive sleep apnoea
15 October, 2024Sulthiame, a drug currently in use for epilepsy, has been shown to reduce symptoms of obstructive sleep apnoea (OSA), according to the results of a recent clinical trial.
